Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies.

Show other versions (1)

In December 2020, an interim recommendation for the use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years was made under Food and Drug Administration's Emergency Use Authorization. In preparation for Biologics License Application approval, we conducted a systematic review and meta-a...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Megan Wallace, Jennifer P Collins, Heidi Moline, Ian D Plumb, Monica Godfrey, Rebecca L Morgan, Doug Campos-Outcalt, Sara E Oliver, Kathleen Dooling, Julia W Gargano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Online Access:https://doi.org/10.1371/journal.pone.0278624
Show all versions (2)

Similar Items